Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
M102 activates both NRF2 and HSF1 transcription factor pathways and is neuroprotective in cell and animal models of amyotrophic lateral sclerosis.
Journal: Molecular neurodegeneration
Published: June 24, 2025
Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease.
Journal: Antibiotics (Basel, Switzerland)
Published: June 04, 2024
Comparison of Culture With Antibiogram to Next-Generation Sequencing Using Bacterial Isolates and Formalin-Fixed, Paraffin-Embedded Gastric Biopsies.
Journal: Gastroenterology
Published: April 19, 2021
National and Regional US Antibiotic Resistance to Helicobacter pylori: Lessons From a Clinical Trial.
Journal: Gastroenterology
Published: December 31, 2020
Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of Helicobacter pylori: Randomized ERADICATE Hp Trial.
Journal: Antibiotics (Basel, Switzerland)
Published: September 10, 2020
Bimodal Release Ondansetron Improves Stool Consistency and Symptomatology in Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Trial.
Journal: The American journal of gastroenterology
Published: July 09, 2020
Rifabutin-Based Triple Therapy (RHB-105) for Helicobacter pylori Eradication: A Double-Blind, Randomized, Controlled Trial.
Journal: Annals of internal medicine
Published: May 05, 2020
Absence of QT prolongation after administration of a 24-mg bimodal-release ondansetron pill (RHB-102).
Journal: The American journal of emergency medicine
Published: December 07, 2019
Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.
Journal: American journal of rhinology & allergy
Published: November 27, 2013
Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women.
Journal: Allergy and asthma proceedings
Published: March 15, 2013
Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.
Journal: Allergy and asthma proceedings
Published: August 04, 2012
Last Updated: 09/26/2026